Fact sheet
Our vaccine manufacturing capability ranges from clinical trial material to commercial production
SFF
Global vaccine manufacturing support
Our global footprint and specialist infrastructure makes us well placed to support pharmaceutical companies with their vaccine manufacturing and aseptic fill and finish needs, no matter where in the world they are based. We have experience with mRNA COVID-19 vaccines in both lyophilised form and liquid vials.
Comprehensive services
- Aseptic fill & finish of biologics and liquid formulations
- Lyophilisation and sterile filling of lyophilised powders
- Dedicated small-scale manufacturing to fill parenteral products for clinical trial
- Commercial-scale manufacturing for high-volume vaccines
- Nitrogen purging for oxidation sensitive vaccines and other formulations
- Filling of vials, ampoules, cartridges and pre-filled syringes
Recipharm has several services that are ideal to support new mRNA and other vaccine manufacturing projects
Related resources
Fact sheet
Our vaccine manufacturing capability ranges from clinical trial material to commercial production
Want to find out more about how we can help you?